MedPath

Neurodevelopmental Outcomes of Preterm Infants Treated for Pain Management With Repeated Doses of Sucrose 24%

Not Applicable
Conditions
Development
Interventions
Drug: Formula or breast milk
Drug: multiple doses of sucrose
Registration Number
NCT01742520
Lead Sponsor
Sheba Medical Center
Brief Summary

The purpose of this study is to determine the effect of sucrose 24% for pain prevention on preterm infants. Our hypothesis is that repeated doses of sucrose 24%, given prior to painful procedure,do not impair neurodevelopmental outcomes of preterm infants

Detailed Description

preterm infants born at 27-33 weeks gestational age at Sheba Medical Center will be recruited for this study. Prior to invasive procedure infants will be treated with pacifier and swaddling as recommended by the American Academy of Pediatrics and Canadian Pediatric Society.

Group 1.Will be treated with Sucrose 24% 0.1-0.5ml on the anterior pat of the tongue 1-3 min prior to invasive procedure.

Group 2. Similar to group 1 but breast milk or formula will replace Sucrose.

Number of invasive procedures/day will be documented

General Movements by Prechtel will be used for developmental assessment at 2,4,6 weeks after birth and at 14-16 weeks corrected age

Griffiths developmental scales (GMDS) will be used at 40 weeks, 14-16 weeks corrected age, and 3-6 month corrected age

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
90
Inclusion Criteria
  • preterm infants born at SMC
Read More
Exclusion Criteria
  • need for intubation
  • surgery
  • need for sedation
  • abnormal head ultrasound
  • genetic abnormalities
  • necrotizing enterocolitis
  • other painful conditions other than routine blood exams
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Formula or Breast MilkFormula or breast milkBreast milk or formula prior to every painful procedure.
Multiple doses of sucrosemultiple doses of sucroseInfants in this group will be treated with Sucrose 24% 0.5-1ml on the anterior pat of the tongue 1-3min prior to every invasive procedure
Primary Outcome Measures
NameTimeMethod
neurodevelopmental outcomesat 6 month corrected age

Griffith mental developmental scaled (gross and fine motor, language, performance, social) and General movements by Prechtel

Secondary Outcome Measures
NameTimeMethod
neurodevelopmentat 15 weeks corrected age

Griffith mental developmental scaled (gross and fine motor, language, performance, social) and General movements by Prechtel

Trial Locations

Locations (1)

Sheba Medical Center

🇮🇱

Ramat Gan, Israel

© Copyright 2025. All Rights Reserved by MedPath